Adipokines and melanocortins in the hepatic manifestation of metabolic syndrome: nonalcoholic fatty liver disease. (Q36748514)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331066%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

review article

1 reference

title

Adipokines and melanocortins in the hepatic manifestation of metabolic syndrome: nonalcoholic fatty liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331066%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331066%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Ancha Baranova

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331066%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Manpreet Randhawa

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331066%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Zobair M Younossi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331066%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331066%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331066%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331066%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331066%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

195-205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331066%20AND%20SRC:MED&resulttype=core&format=json

Banting lecture 1988. Role of insulin resistance in human disease

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Etiopathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Nonalcoholic fatty liver disease and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Nonalcoholic fatty liver disease: an agenda for clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Adipose tissue, inflammation, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

The adipocyte-myocyte axis in insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Pathways leading to muscle insulin resistance--the muscle--fat connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Ghrelin: from somatotrope secretion to new perspectives in the regulation of peripheral metabolic functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Obesity, adiponectin and vascular inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Role of adiponectin in human skeletal muscle bioenergetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Cardioprotection by adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Adiponectin as a protective factor in hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Plasma adiponectin is decreased in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Adiponectin as a marker of success in intracytoplasmic sperm injection/embryo transfer cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Adiponectin and its receptors in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Leptin signaling in the central nervous system and the periphery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Serum leptin levels in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Peripheral metabolic actions of leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Independent association between plasma leptin and C-reactive protein in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

The role of leptin in progression of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Leptin in the field of hepatic fibrosis: a pivotal or an incidental player?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Increased expression of Ob-Rb and its relationship with the overexpression of TGF-beta1 and the stage of fibrosis in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Physiologic concentrations of leptin increase collagen production by non-immortalized human hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Insulin resistance and obesity: resistin, a hormone secreted by adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Regulation of insulin signalling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

FIZZ1 stimulation of myofibroblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

FIZZ1/RELMα, a Novel Hypoxia-Induced Mitogenic Factor in Lung With Vasoconstrictive and Angiogenic Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Comparative studies of resistin expression and phylogenomics in human and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Recombinant human FIZZ3/resistin stimulates lipolysis in cultured human adipocytes, mouse adipose explants, and normal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Role of resistin in obesity, insulin resistance and Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Apelin, a newly identified adipokine up-regulated by insulin and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Apelin and its receptor are expressed in human osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

TNFalpha up-regulates apelin expression in human and mouse adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Expression and characterization of melanin-concentrating hormone receptors on mammalian cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Melanin-concentrating hormone activates signaling pathways in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Collagen metabolism is a novel target of the neuropeptide alpha-melanocyte-stimulating hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Single injection of naked plasmid encoding alpha-melanocyte-stimulating hormone protects against thioacetamide-induced acute liver failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Regulation of adipose tissue leptin secretion by alpha-melanocyte-stimulating hormone and agouti-related protein: further evidence of an interaction between leptin and the melanocortin signalling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

ACTH and alpha-MSH inhibit leptin expression and secretion in 3T3-L1 adipocytes: model for a central-peripheral melanocortin-leptin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Alpha-melanocyte-stimulating hormone (MSH) inhibits insulin secretion in HIT-T 15 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Signaling pathways implicated in alpha-melanocyte stimulating hormone-induced lipolysis in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Role of the melanocortin system in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Alpha-melanocyte-stimulating hormone gene therapy reverses carbon tetrachloride induced liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Alpha-melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-alpha and interleukin-1beta gene expression following transient cerebral ischemia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Overweight humans are resistant to the weight-reducing effects of melanocortin4-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-alpha in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.2.195

21 January 2018

Identifiers

DOI

10.1586/14737159.7.2.195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331066%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference